FibroBiologics, Inc. (FBLG) News
Track canonical SquawkNews coverage tagged to FBLG, FibroBiologics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
FibroBiologics Granted European Patent
FibroBiologics gets patent for cartilage regeneration
EQUITY | Aug 05, 2026, 12:30 PM UTC
L
FBLG - FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate - Click
FBLG - FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
EARNINGS | Jul 31, 2026, 09:35 PM UTC
M
FBLG Announces $9M Placement
FibroBiologics announces up to $9.0 million private placement priced at-the-market under Nasdaq rules
EQUITY | Jun 26, 2026, 12:31 PM UTC
M
FBLG Receives Patent Notice
FibroBiologics Receives U.S. Patent And Trademark Office Notice Of Allowance For Patented Application Entitled Therapeutic Use Of Fibroblasts In Wound Healing
EQUITY | Jun 22, 2026, 12:35 PM UTC
M
FBLG Receives US Patent
FBLG - FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound HealingAllowed claims directly support the Company's ongoing Phase 1/2 clinical trial of CYWC628 i
EQUITY | Jun 22, 2026, 12:31 PM UTC